2020
DOI: 10.1038/s41598-020-71755-8
|View full text |Cite
|
Sign up to set email alerts
|

Case studies of clinical hemodialysis membranes: influences of membrane morphology and biocompatibility on uremic blood-membrane interactions and inflammatory biomarkers

Abstract: End stage renal disease (ESRD) patients depend on hemodialysis (HD) as a life-sustaining treatment, but HD membrane properties play a critical role in blood activation during HD and can lead to severe patient outcomes. This study reports on a series of investigations on the common clinical HD membranes available in Canadian hospitals to explore the key reasons behind their susceptibility to blood activation and unstable cytokine. Clinical HD membranes composed of cellulose triacetate (CTA) and polyvinylpyrroli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
43
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 53 publications
(46 citation statements)
references
References 44 publications
3
43
0
Order By: Relevance
“…34 Our research group recently reported a series of investigations on the common clinical HD membranes available in Canadian hospitals (PAES and CTA) to explore the key reasons behind their susceptibility to blood activation and unstable cytokines. [35][36][37] We also reported the improved biocompatibility of PES clinical HD membranes modified with novel ZW copolymers. 29 We also reported how undesired reactions are related to the bio-incompatibility of dialysis membranes and summarized recent advances in hemocompatibility and guidelines for future HD membrane development.…”
mentioning
confidence: 78%
See 1 more Smart Citation
“…34 Our research group recently reported a series of investigations on the common clinical HD membranes available in Canadian hospitals (PAES and CTA) to explore the key reasons behind their susceptibility to blood activation and unstable cytokines. [35][36][37] We also reported the improved biocompatibility of PES clinical HD membranes modified with novel ZW copolymers. 29 We also reported how undesired reactions are related to the bio-incompatibility of dialysis membranes and summarized recent advances in hemocompatibility and guidelines for future HD membrane development.…”
mentioning
confidence: 78%
“…The binding interactions of the human serum proteins to the membrane is the initial step of the membrane fouling in the hemodialysis process which leads to performance loss. 35,46,47 Accordingly, binding tendency reflects the initial step of fouling and activation of proteins when the HD process starts. concentration of such compounds in the blood, in the case of hypertension as a common side effect of hemodialysis).…”
Section: Molecular Docking Simulationsmentioning
confidence: 99%
“…Consequently, the CTA membranes resulted in poorer clearance of uremic toxins, but exhibited lower fibrinogen adsorption and caused a less severe increase in complement and inflammatory factors. 51 Studies have also compared the biocompatibility of different types of polysulfone dialyzers. 50 , 52 A study by Koga et al 52 showed that 5 different polysulfone hemodialysis membranes caused different levels of cell activation, fibrin absorption, and oxidative stress, with NV-U membranes proving to be the most biocompatible.…”
Section: Complement Activation In Hemodialysismentioning
confidence: 99%
“…For the active layer of the CTA membrane, the major spectral feature was the band around 1733 cm −1 that corresponds to the ester carbonyl group (C=O ester), and other characteristic peaks around 1042 and 1230 cm −1 can be assigned to asymmetric and symmetric stretching of C–O bonds [ 43 , 44 ]. The small shoulder around 2960 cm −1 accounted for the C–H bonds [ 45 ]. Figure 15 b compares the AL surface of the CTA membrane for pristine, fouled, and cleaned membranes.…”
Section: Resultsmentioning
confidence: 99%